Clinical Trials Browser

Observational × Recurrence × Combined Modality Therapy × Clear all

NCT06993506 2025-05-29

Real-world Study of SKB264 Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer

Not yet recruiting

Neoplasm Metastasis, Recurrence